Boca Raton, FL (August 13, 2018) – Florida Pharmaceutical Products, Inc., a company involved in the development of Generic Pharmaceuticals, was acquired by Woodfield Distribution, LLC, a Boca Raton, FL based Logistics Services Provider. Terms were not disclosed. Florida Pharmaceutical Products, Inc., focuses on improving patient outcomes with generic medications spanning a broad therapeutic range.  Investments fund research to identify new treatments and guiding strong product candidates thro...

Introduction A national manufacturer of a popular sleep-aid caplet selected WDSrx to manage their sample distribution program. Healthcare professionals received a box containing product samples, promotional items and informational materials.  Soon after the program launch, WDSrx project managers determined that changes to the package design would save cost and increase visual appeal.  The new configuration achieved desired results due to the ability of the WDSrx team to create a customized hea...

FRIENDS WITH BENEFITS New conventional and virtual manufacturers focus on developing commercial products and often under-estimate the complexity of bringing their medications to market. Smaller manufacturers unacquainted with logistics that take it upon themselves to deliver their products to retailers and wholesalers soon discover the process is more costly and difficult than they imagined, particularly when retailers impose financial penalties for rejected or late deliveries. It may seem count...

Following the announcement of our new 63,500-square-foot facility opening in South Brunswick, New Jersey, WDSrx was featured on the following news websites: Princeton Info New Jersey Business Magazine American Shipper TAPinto- Health & Wellness NJBiz    ...

Refreshing Idea Makes Online Pharmaceutical Returns Faster, Easier, ‘Kind Of Fun’ A Web-Based System For Healthcare Practitioners Reduces Paperwork and Increases Patient Interaction. Boca Raton, FL; November 1, 2017 — Healthcare Managed Service Organizations (MSOs) managing physicians’ and surgeons’ offices, urgent care centers and other medical facilities dispensing medications are increasingly distracted by time lost managing administrative duties including processing dru...

Companies outside the United States manufacturing pharmaceutical drug products, supplements, components and API for the American market may benefit by establishing a Vendor-Managed-Inventory (VMI) program with a reputable third party logistics (3PL) provider.  VMI programs include multiple services to anticipate issues that may affect movement of products within the supply chain. Any delay for pharmaceutical drug products carries significant costs, since the U.S. is the world’s largest drug i...

Pharmaceutical Reverse Logistics Keeps Environment and Streets Clean View the WDSrx article in Reverse Logistics Magazine’s 85th Edition...

...

In recent years, the pharmaceutical industry has acted like a student who is not sure whether he or she has studied the proper material for an upcoming exam.  The deadline for the next phase of DSCSA serialization compliance passes on November 27, 2017.  It’s too late to cram for the test. HIDDEN HEROES Manufacturers that delayed studying up till now won’t catch up no matter how many all-nighters they put in until November, unless they get a study partner to help achieve serialization.  T...